| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| February 2017 - 50 products |
|
| | | IP | CI | | Fexo Pollen Sandoz 120 mg | 30 | PR | PR | k.A. | | Coated tablets: Fexofenadini Hydrochloridum 120 mg | Sandoz
Pharmaceuticals AG | D | FB | | G |  |
| | | IP | CI | | Fexofenadin Sandoz 120 mg | 10 | 2.85 | 5.25 | 10 % | | Coated tablets: Fexofenadini Hydrochloridum 120 mg | Sandoz
Pharmaceuticals AG | ● D / SL / SG | FB | | G | |
| | | IP | CI | | Fexofenadin Sandoz 120 mg | 30 | 7.70 | 14.20 | 10 % | | Coated tablets: Fexofenadini Hydrochloridum 120 mg | Sandoz
Pharmaceuticals AG | ● D / SL / SG | FB | | G | |
| | | IP | CI | | Fexofenadin Sandoz 180 mg | 10 Tablet(s) | 3.91 | 7.20 | 10 % | | Coated tablets: Fexofenadini Hydrochloridum 180 mg | Sandoz
Pharmaceuticals AG | ● D / SL / SG | FB | | G | |
| | | IP | CI | | Fexofenadin Sandoz 180 mg | 30 Tablet(s) | 10.59 | 19.55 | 10 % | | Coated tablets: Fexofenadini Hydrochloridum 180 mg | Sandoz
Pharmaceuticals AG | ● D / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/12,5 mg | 28 | 13.46 | 31.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/12,5 mg | 98 | 40.04 | 59.95 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/25 mg | 28 | 13.46 | 31.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/25 mg | 98 | 40.04 | 59.95 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/12,5 mg | 28 | 17.17 | 35.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/12,5 mg | 98 | 51.08 | 72.00 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/25 mg | 28 | 17.17 | 35.10 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/25 mg | 98 | 51.08 | 72.00 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 5 mg | 30 | 7.12 | 16.95 | 10 % | | Coated tablets: Rosuvastatinum 5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 5 mg | 50 | 11.87 | 29.35 | 10 % | | Coated tablets: Rosuvastatinum 5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 5 mg | 100 | 23.75 | 42.20 | 10 % | | Coated tablets: Rosuvastatinum 5 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 10 mg | 30 | 8.12 | 18.05 | 10 % | | Coated tablets: Rosuvastatinum 10 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 10 mg | 50 | 13.53 | 31.15 | 10 % | | Coated tablets: Rosuvastatinum 10 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 10 mg | 100 | 27.08 | 45.80 | 10 % | | Coated tablets: Rosuvastatinum 10 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 20 mg | 30 | 11.78 | 29.20 | 10 % | | Coated tablets: Rosuvastatinum 20 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 20 mg | 50 | 19.63 | 37.75 | 10 % | | Coated tablets: Rosuvastatinum 20 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Rosuvastatin Sandoz 20 mg | 100 | 39.28 | 59.05 | 10 % | | Coated tablets: Rosuvastatinum 20 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Ezetimib Spirig HC | 28 | 16.98 | 34.90 | 10 % | | Tablets: Ezetimibum 10 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Ezetimib Spirig HC | 98 | 59.93 | 81.60 | 10 % | | Tablets: Ezetimibum 10 mg | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| L | | IP | CI | CM | Ezetimibe Organon 10 mg | 28 | 17.25 | 35.15 | 10 % | | Tablets: Ezetimibum 10 mg | Organon GmbH | B / SL / SG | FB | | G | |
| L | | IP | CI | CM | Ezetimibe Organon 10 mg | 98 | 60.27 | 81.95 | 10 % | | Tablets: Ezetimibum 10 mg | Organon GmbH | B / SL / SG | FB | | G | |
| L | | IP | | | Keytruda 100 mg/4 ml | 2 | 4407.68 | 4810.05 | 10 % | | Concentrate for infusion: Pembrolizumabum 100mg / 4ml | MSD Merck Sharp &
Dohme AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Ninlaro 2.3 mg | 3 x 1 | 6002.10 | 6465.95 | 10 % | | Capsules: Ixazomibum 2.3 mg | Takeda Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Ninlaro 3.0 mg | 3 x 1 | 6002.10 | 6465.95 | 10 % | | Capsules: Ixazomibum 3 mg | Takeda Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Ninlaro 4.0 mg | 3 x 1 | 6002.10 | 6465.95 | 10 % | | Capsules: Ixazomibum 4 mg | Takeda Pharma AG | A / SL | FB | | G | |
| | | IP | | | Omegaflex peri,
Infusionsemulsion 1250 ml | 5 x 1250 ml | PR | PR | k.A. | | 2 Active Agents
4 Active Agents
22 Active Agents | B. Braun Medical AG | B | FB | | G | |
| | | IP | | | Omegaflex peri,
Infusionsemulsion 1875 ml | 5 x 1875 ml | PR | PR | k.A. | | 2 Active Agents
4 Active Agents
22 Active Agents | B. Braun Medical AG | B | FB | | G | |
| | | IP | | | Omegaflex plus,
Infusionsemulsion 1250 ml | 5 x 1250 ml | PR | PR | k.A. | | 3 Active Agents
3 Active Agents
4 Active Agents
22 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | | | Omegaflex plus,
Infusionsemulsion 1875 ml | 5 x 1875 ml | PR | PR | k.A. | | 22 Active Agents
3 Active Agents
4 Active Agents
22 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | | | Omegaflex special ohne
Elektrolyte, Emulsion zur
Infusion 625 ml | 5 x 625 ml | PR | PR | k.A. | | 16 Active Agents
Glucosum 90 g
3 Active Agents
16 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | | | Omegaflex special ohne
Elektrolyte, Emulsion zur
Infusion 1250 ml | 5 x 1250 ml | PR | PR | k.A. | | Glucosum 180 g
3 Active Agents
16 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | | | Omegaflex special ohne
Elektrolyte, Emulsion zur
Infusion 1875 ml | 5 x 1875 ml | PR | PR | k.A. | | Glucosum 270 g
3 Active Agents
16 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | | | | Atemluft medizinal
Carbagas 100% | 4 l | PR | PR | k.A. | | Inhalation gas: Aer Medicinalis 100 % | Carbagas AG | E | FB | | G | |
| | | | | | Atemluft medizinal
Carbagas 100% | 10 l | PR | PR | k.A. | | Inhalation gas: Aer Medicinalis 100 % | Carbagas AG | E | FB | | G | |
| | | | | | Atemluft medizinal
Carbagas 100% | 30 l | PR | PR | k.A. | | Inhalation gas: Aer Medicinalis 100 % | Carbagas AG | E | FB | | G | |
| | | | | | Atemluft medizinal
Carbagas 100% | 50 l | PR | PR | k.A. | | Inhalation gas: Aer Medicinalis 100 % | Carbagas AG | E | FB | | G | |
| | | | | | Atemluft medizinal
Carbagas 100% | 12 x 50 l | PR | PR | k.A. | | Inhalation gas: Aer Medicinalis 100 % | Carbagas AG | E | FB | | G | |
| | | IP | | | Omegaflex special 625 ml | 5 x 625 ml | PR | PR | k.A. | | Infusion emulsion: 3 Active Agents
Infusion emulsion: 3 Active Agents
Infusion emulsion: 4 Active Agents
Infusion emulsion: 22 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | | | Omegaflex special 1250 ml | 5 x 1250 ml | PR | PR | k.A. | | Infusion emulsion: 3 Active Agents
Infusion emulsion: 3 Active Agents
Infusion emulsion: 4 Active Agents
Infusion emulsion: 22 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | | | Omegaflex special 1875 ml | 5 x 1875 ml | PR | PR | k.A. | | Infusion emulsion: 3 Active Agents
Infusion emulsion: 3 Active Agents
Infusion emulsion: 4 Active Agents
Infusion emulsion: 22 Active Agents | B. Braun Medical SA | B | FB | | G | |
| | | IP | CI | | Fexo Pollen Sandoz 120 mg | 10 Tablet(s) | PR | PR | k.A. | | Coated tablets: Fexofenadini Hydrochloridum 120 mg | Sandoz
Pharmaceuticals AG | ● D | FB | | G | |
| | | IP | CI | | Rosuvastatin Sandoz 40 mg | 30 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 40 mg | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | IP | CI | | Rosuvastatin Sandoz 40 mg | 50 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 40 mg | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | IP | CI | | Rosuvastatin Sandoz 40 mg | 100 | PR | PR | k.A. | | Coated tablets: Rosuvastatinum 40 mg | Sandoz
Pharmaceuticals AG | B | FB | | G | |
| | | IP | CI | | Kyleena 19.5 mg | | PR | PR | k.A. | | Gestagen abegebendes Intrauterinsystem: Levonorgestrelum 19.5 mg | Bayer (Schweiz) AG | B / LPPV | FB | | G | |
